The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
The Pharmacokinetic and Pharmacodynamic Properties of Vancomycin
Abstract
Vancomycin is one of only a few antibiotics available to treat patients infected with methicillin-resistant Staphylococcus aureus and methicillin-resistant, coagulase-negative Staphylococcus species. Therefore, understanding the clinical implications of the pharmacokinetic and pharmacodynamic properties of vancomycin is a necessity for clinicians. Vancomycin is a concentration-independent antibiotic (also referred to as a "time-dependent" antibiotic), and there are factors that affect its clinical activity, including variable tissue distribution, inoculum size, and emerging resistance. This article reviews the pharmacokinetic and pharmacodynamic data related to vancomycin and discusses such clinical issues as toxicities and serum concentration monitoring.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200405-644st · Cited by 5,877
Infectious Diseases Society of America
Enders, J. F. (1969) · Journal of Infectious Diseases · doi:10.1093/infdis/119.3.317 · Cited by 3,286
Moise-Broder, P. A., Forrest, A., Birmingham, M. C., & Schentag, J. J. (2004) · Clinical Pharmacokinetics · doi:10.2165/00003088-200443130-00005 · Cited by 757
Howden, B. P., Ward, P. B., Charles, P. G. P., Korman, T. M., Fuller, A., Cros, P. D., Grabsch, E. A., Roberts, S. A., Robson, J., Read, K., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/381202 · Cited by 484
Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981
Farber, B. F., & Moellering, R. C. (1983) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.23.1.138 · Cited by 432
Nephrotoxicity of vancomycin, alone and with an aminoglycoside
Rybak, M. J., Albrecht, L. M., Boike, S. C., & Chandrasekar, P. H. (1990) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/25.4.679 · Cited by 388
Self-citationCharles, P. G. P., Ward, P. B., Johnson, P. D. R., Howden, B. P., & Grayson, M. L. (2004) · Clinical Infectious Diseases · doi:10.1086/381093 · Cited by 384
Pharmacokinetics of vancomycin in patients with various degrees of renal function
Matzke, G. R., McGory, R. W., Halstenson, C. E., & Keane, W. F. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.25.4.433 · Cited by 362
Clinical Pharmacokinetics of Vancomycin
Matzke, G. R., Zhanel, G. G., & Guay, D. R. P. (1986) · Clinical Pharmacokinetics · doi:10.2165/00003088-198611040-00001 · Cited by 360
Liu, C., & Chambers, H. F. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3040-3045.2003 · Cited by 321
Weinstein, R. A., & Fridkin, S. K. (2001) · Clinical Infectious Diseases · doi:10.1086/317542 · Cited by 304
Lamer, C., de Beco, V, Soler, P., Calvat, S., Fagon, J. Y., Dombret, M. C., Farinotti, R., Chastre, J., & Gibert, C. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.2.281 · Cited by 297
LaPlante, K. L., & Rybak, M. J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4665-4672.2004 · Cited by 284
Self-citationPenetration of vancomycin into human lung tissue
Cruciani, M., Gatti, G., Lazzarini, L., Furlan, G., Broccali, G., Malena, M., Franchini, C., & Concia, E. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/38.5.865 · Cited by 264
Vancomycin pharmacokinetics in patients with various degrees of renal function
Rodvold, K. A., Blum, R. A., Fischer, J. H., Zokufa, H. Z., Rotschafer, J. C., Crossley, K. B., & Riff, L. J. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.6.848 · Cited by 249
Vancomycin pharmacokinetics in normal and morbidly obese subjects
Blouin, R. A., Bauer, L. A., Miller, D. D., Record, K. E., & Griffen, W. O. (1982) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.21.4.575 · Cited by 233
Pharmacokinetics of vancomycin: observations in 28 patients and dosage recommendations
Rotschafer, J. C., Crossley, K., Zaske, D. E., Mead, K., Sawchuk, R. J., & Solem, L. D. (1982) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.22.3.391 · Cited by 185
Pharmacokinetics of vancomycin
Moellering, R. C. (1984) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/14.suppl_d.43 · Cited by 178
A prospective study of adverse reactions associated with vancomycin therapy
Sorrell, T. C., & Collignon, P. J. (1985) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/16.2.235 · Cited by 175
Albanèse, J., Léone, M., Bruguerolle, B., et al. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.5.1356-1358.2000 · Cited by 155
Moore, M. R., Perdreau‐Remington, F., & Chambers, H. F. “. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1262-1266.2003 · Cited by 149
Antimicrobial Pharmacodynamics in Theory and Clinical Practice
Nightingale, & Mur (2007) · CRC Press eBooks · doi:10.3109/9781420017137 · Cited by 142
Cimino, M. A., Rotstein, C., Slaughter, R. L., & Emrich, L. J. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90947-8 · Cited by 128
Löwdin, E., Odenholt, I., & Cars, O. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.10.2739 · Cited by 126
Lamp, K. C., Rybak, M. J., Bailey, E. M., & Kaatz, G. W. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.12.2709 · Cited by 124
Self-citationVancomycin pharmacokinetics, renal handling, and nonrenal clearances in normal human subjects
Golper, T. A., Noonan, H. M., Elzinga, L. W., Gilbert, D. N., Brummett, R. E., Anderson, J. L., & Bennett, W. M. (1988) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1988.74 · Cited by 121
Vancomycin- and erythromycin-induced hearing loss in humans
Brummett, R. E., & Fox, K. E. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.6.791 · Cited by 119
Rybak, M. J., & Akins, R. L. (2001) · Drugs · doi:10.2165/00003495-200161010-00001 · Cited by 112
Self-citationElting, L. S., Rubenstein, E. B., Kurtin, D., Rolston, K. V. I., Fangtang, J. T., Martin, C. G., RAAD, I. I., Whimbey, E. E., Manzullo, E. F., & Bodey, G. P. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981215)83:12<2597::aid-cncr27>3.0.co;2-l · Cited by 109
Larsson, A. J., Walker, K. J., Raddatz, J. K., & Rotschafer, J. C. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/38.4.589 · Cited by 105
Vancomycin enhancement of experimental tobramycin nephrotoxicity
Wood, C. A., Kohlhepp, S. J., Kohnen, P. W., Houghton, D. C., & Gilbert, D. N. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.30.1.20 · Cited by 86
Toxicology of Vancomycin in Laboratory Animals
Wold, J. S., & Turnipseed, S. A. (1981) · Clinical Infectious Diseases · doi:10.1093/clinids/3.supplement_2.s224 · Cited by 77
Vancomycin Serum Protein Binding Determination by Ultrafiltration
Ackerman, B. H., Taylor, E. H., Olsen, K. M., Abdel-Malak, W., & Pappas, A. A. (1988) · Annals of Pharmacotherapy · doi:10.1177/106002808802200404 · Cited by 58
Lundstrom, T. S., & Sobel, J. D. (2004) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2004.04.014 · Cited by 55
Vancomycin Protein Binding in Patients with Infections Caused by Staphylococcus Aureus
Albrecht, L. M., Rybak, M. J., Warbasse, L. H., & Edwards, D. J. (1991) · DICP · doi:10.1177/106002809102500701 · Cited by 41
Self-citationVANCOMYCIN, TRIMETHOPRIMSULFAMETHOXAZOLE, AND RIFAMPIN
Lundstrom, T. S., & Sobel, J. D. (1995) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(20)30695-4 · Cited by 27
Protein binding of vancomycin in a patient with immunoglobulin A myeloma
Cantú, T. G., Dick, J. D., Elliott, D., Humphrey, R. L., & Kornhauser, D. M. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.7.1459 · Cited by 27
An experimental study of vancomycin-induced cochlear damage
Tange, R. A., Kieviet, H. L., van Marle, J., Bagger-Sj�b�ck, D., & Ring, W. (1989) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/bf00457456 · Cited by 20
Stanley, D., McGrath, B. J., Lamp, K. C., & Rybak, M. J. (1994) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1994.tb02786.x · Cited by 10
Self-citation
Cited by
Rybak, M., Lomaestro, B., Rotschafer, J. C., Moellering, R., Craig, W., Billeter, M., Dalovisio, J. R., & Levine, D. P. (2009) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp080434 · Cited by 1,795
Self-citationRybak, M. J., Le, J., Lodise, T. P., Levine, D. P., Bradley, J. S., Liu, C., Mueller, B. A., Pai, M. P., Wong-Beringer, A., Rotschafer, J. C., et al. (2020) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxaa036 · Cited by 1,202
Self-citationPharmacokinetic issues for antibiotics in the critically ill patient
Roberts, J. A., & Lipman, J. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181961bff · Cited by 862
Hidayat, L. K., Hsu, D. I., Quist, R., Shriner, K. A., & Wong-Beringer, A. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.19.2138 · Cited by 860
van Hal, S. J., Paterson, D. L., & Lodise, T. P. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01568-12 · Cited by 639
Metadata
- Authors
- Rybak, M. J.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-01-01
- Volume
- 42
- Issue
- Supplement_1
- Pages
- S35-S39
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2140147718
- Cited by
- 774
- References
- 39
- FWCI
- 10.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.